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TheDrosophila GATA factor Serpent interacts with the RUNX factor Lozenge to activate the crystal cell program, whereas SerpentNC binds the
Friend of GATA protein U-shaped to limit crystal cell production. Here, we identified a lozenge minimal hematopoietic cis-regulatory module and
showed that lozenge–lacZ reporter-gene expression was autoregulated by Serpent and Lozenge. We also showed that upregulation of u-shaped was
delayed until after lozenge activation, consistent with our previous results that showed u-shaped expression in the crystal cell lineage is dependent on
both Serpent and Lozenge. Together, these observations describe a feed forward regulatory motif, which controls the temporal expression of
u-shaped. Finally, we showed that lozenge reporter-gene activity increased in a u-shaped mutant background and that forced expression of
SerpentNC with U-shaped blocked lozenge- and u-shaped-lacZ reporter-gene activity. This is the first demonstration of GATA:FOG regulation of
Runx and Fog gene expression. Moreover, these results identify components of a Serpent cross-regulatory sub-circuit that can modulate lozenge
expression. Based on the sub-circuit design and the combinatorial control of crystal cell production, we present a model for the specification of a
dynamic bi-potential regulatory state that contributes to the selection between a Lozenge-positive and Lozenge-negative state.
© 2007 Elsevier Inc. All rights reserved.Keywords: Drosophila; Friend of GATA; GATA; Hematopoiesis; Linage commitment; RUNXIntroduction
Hematopoiesis is a dynamic process that produces the
various blood cell lineages from a single hematopoietic stem
cell and is regulated by key lineage-specific factors (Orkin,
2000; Zhu and Emerson, 2002; Warren and Rothenberg, 2003).
When viewed in the context of all known genetic interactions,
the complexity of the processes that control hematopoiesis can
be appreciated, but not readily understood (Swiers et al., 2006).
An understanding of the interactions in terms of gene activation
or repression, coupled with information about cis-regulatory
inputs, has revealed mechanistic details about the modular sub-
circuits that together describe these processes and development
in general (Swiers et al., 2006; Oliveri and Davidson, 2007).
Moreover, simple genetic model organisms provide an
opportunity to analyze these interactions in vivo, thereby⁎ Corresponding author. Fax: +1 410 706 8121.
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doi:10.1016/j.ydbio.2007.08.015providing a direct link between the genomic programs that
encode them and the biological functions they control. The
Drosophila model system has been used to identify conserved
key factors and investigate their function during hematopoiesis
(Dearolf, 1998; Fossett and Schulz, 2001; Evans et al., 2003;
Meister and Lagueux, 2003; Sorrentino et al., 2005; Harten-
stein, 2006; Crozatier and Meister, 2007). In order to more
fully understand Drosophila hematopoiesis, we characterized
the role of Serpent (Srp) cross-regulation of Lozenge (Lz) and
U-shaped (Ush) in the crystal cell lineage.
The blood system of the fly lacks the complexity seen in
vertebrates. Nevertheless, cross-species comparisons have
shown that fundamental aspects of hematopoiesis are conserved
across taxa (Fossett and Schulz, 2001; Evans et al., 2003; Fossett
et al., 2003; Meister and Lagueux, 2003; Sorrentino et al., 2005;
Hartenstein, 2006; Crozatier andMeister, 2007).Drosophila has
two primary blood cell types, plasmatocytes and crystal cells,
which have similar functions to the vertebrate myeloid lineages
(Rizki, 1978; Dearolf, 1998; Evans et al., 2003). Crystal cells,
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wound repair and xenobiotic encapsulation (Rizki, 1978).
Plasmatocytes are operational macrophages and synthesize
antimicrobials (Rizki, 1978; Tepass et al., 1994; Dearolf,
1998). Like their vertebrate counterparts, these cells develop
from a common hematopoietic progenitor (Rizki, 1978; Tepass
et al., 1994; Dearolf, 1998; Lebestky et al., 2000; Lanot et al.,
2001). Both vertebrate and Drosophila hematopoiesis consists
of two spatially and temporally distinct periods or waves. In
Drosophila, the first hematopoietic wave begins in the early
embryonic head mesoderm. The second wave begins in
embryogenesis and continues throughout larval development
within a specialized hematopoietic organ, called the lymph gland
(Dearolf, 1998; Lebestky et al., 2000; Lanot et al., 2001; Fossett
and Schulz, 2001; Evans et al., 2003; Hartenstein, 2006;
Crozatier and Meister, 2007).
Srp, similar to vertebrate GATA-2, is positioned at the apex of
hematopoiesis and, as such, is required for the production of
hemocyte precursors (Rehorn et al., 1996; Sam et al., 1996). In
this role, Srp acts upstream of Glial cells missing (Gcm) and the
RUNX factor Lz, which are required later for plasmatocyte and
crystal cell production, respectively (Bernardoni et al., 1997;
Lebestky et al., 2000; Kammerer and Giangrande, 2001;
Alfonso and Jones, 2002). Of the conserved hematopoietic
regulators, the GATA, Friend of GATA (FOG), and RUNX
protein families are of particular interest because pair-wise
interactions between GATA and FOG or between GATA and
RUNX regulate both vertebrate and Drosophila hematopoiesis
(Tsang et al., 1997, 1998; Querfurth et al., 2000; Elagib et al.,
2003; Fossett et al., 2003;Waltzer et al., 2003; Cantor andOrkin,
2005, Ferjoux et al., 2007). Moreover, Srp acts as a contextual
switch between RUNX activation and FOG repression of the
crystal cell lineage (Fossett et al., 2003). GATA transcriptional
regulators generally have two zinc-finger domains. The C-
terminal zinc-finger binds the DNA recognition sequence,
WGATAR (Cantor and Orkin, 2005). The N-terminal zinc-
finger interacts with FOG proteins; and the GATA:FOG
complex modifies transcription by either activating or antag-
onizing activity, depending upon the gene regulatory context
(Crispino et al., 1999; Lu et al., 1999; Svensson et al., 1999;
Tevosian et al., 1999; Chang et al., 2002; Letting et al., 2004;
Hong et al., 2005; Cantor and Orkin, 2005; Lowry and Mackay,
2006). The srp gene is alternatively spliced to produce either a
single C-terminal zinc-finger isoform (SrpC) or the canonical
dual zinc-finger protein (SrpNC). The FOGprotein Ush interacts
with SrpNC, but not SrpC, which lacks the N-terminal zinc-
finger (Waltzer et al., 2002; Fossett et al., 2003). RUNX proteins
bind DNA through the conserved Runt domain (Tracey and
Speck, 2000; Speck and Gilliland, 2002; Rennert et al., 2003;
Anglin and Passaniti, 2004). In general, RUNX activity is
influenced by a variety of interacting factors, including GATA
factors (Coffman, 2003; Elagib et al., 2003; Fossett et al., 2003;
Waltzer et al., 2003, Ferjoux et al., 2007). Of the three
mammalian Runx genes, Runx1 is required for hematopoiesis
(Otto et al., 2003) and is one of the most frequent targets of
chromosomal translocations associated with human leukemia
(Okuda et al., 1996; Speck and Gilliland, 2002; De Bruijn andSpeck, 2004). Currently, there is a lack of information about the
role of Runx1 in hematopoietic gene regulatory networks
(Swiers et al., 2006; Otto et al., 2003).
Srp, Lz and Ush act combinatorially to regulate crystal cell
production. Both SrpC and SrpNC can interact with Lz to
activate the crystal cell program (Fossett et al., 2003; Waltzer et
al., 2003), whereas only SrpNC interacts with Ush to repress
crystal cell production (Fossett et al., 2003). This suggests that
Srp acts as a contextual switch, mediating cross-talk between
crystal cell activation and repression pathways. In order to
increase our understanding of the mechanistic basis for this
contextual switch, and how it regulates crystal cell production,
we investigated the cis- and trans-regulation of lz and ush.
Collectively, our data provide evidence for a Srp cross-
regulatory sub-circuit that regulates lz and ush expression.
Based on these results, we present a model for the specification
of a dynamic bi-potential regulatory state that contributes to the
selection between a Lz-positive and Lz-negative state.
Materials and methods
Fly strains
Fly stocks were maintained at 23 °C on standard food, and w1118 was used as
the wild-type stock. The following fly lines were used in this study and are
described elsewhere: ush1/SM6,Roi,eve–lacZ; upstream activation sequence
(UAS)–ush; UAS–srpNC; UAS–srpNCV421G; and twi–Gal4 (Fossett et al., 2001,
2003). The following strains were generous gifts from colleagues: lz–Gal4;UAS–
GFP (J. Pollock, Duquesne University); UAS–lz (J. Canon and U. Banerjee,
University of California, Los Angeles, CA); UAS–srpC (D. K. Hoshizaki,
University of Nevada, Las Vegas, NV); and UAS–srpNC;UAS–lz (K. M.
Gajewski, University of Texas, M. D. Anderson Cancer Center, Houston, TX).
UAS–srpNC,UAS–ush stock was constructed using genetic recombination
between UAS–transgenes located on chromosome II. The generation of strains
carrying lz–lacZ transgenes is described below.
Generation of transgenic animals carrying lz–lacZ fusion constructs
Overlapping DNA fragments of the lz 1.5 kb 5′ UTR genomic DNA region
were analyzed for their ability to direct lacZ reporter-gene expression in crystal
cells. This was accomplished by generating PCR fragments that were either
cloned directly into the P-element CaSpeR-Hsp43-AUG-βgal (Chab) germline
transformation vector (Thummel et al., 1988), or first cloned into pCR-II TOPO
cloning vector (Invitrogen) and subsequently into Chab vector. Site-directed
mutations (SDM) were introduced into DNA fragments as described previously
(Muratoglu et al., 2006). The oligonucleotide primers used to generate point
mutations in DNA fragments are available upon request.
TheDNA sequence of each recombinant vector was verified prior to injection.
w1118 embryos were injected with the recombinant vectors by Model Systems
Genomics, Duke University, or Rainbow Transgenic Flies, Inc., Newbury Park,
CA. Germline transformants were established according to previously described
methods and were screened for tissue-specific lacZ expression using immuno-
histochemical staining analysis as previously described (Gajewski et al., 1997).
At least six independent lines were generated and tested for each construct.
Determination of the lz–Gal4 chromosomal insertion site
Plasmid rescue was used to identify the lz genomic sequences that flank the
pGawB insertion (Pirrotta, 1986). Briefly, genomic DNA was isolated from
lz–Gal4 fly lines. The DNA was cut with MspI or DraI, each having a single
restriction site within the pGawB plasmid insert. Ligation of this restriction
digest produced a circular template for PCR. Specific primers for the pGawB
plasmid, but facing the flanking sequences, were used to produce a pGawB/
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TOPO cloning vector (Invitrogen) and sent to The Biopolymer Core Facility at
the University of Maryland, Baltimore, for sequence analysis.
Immunohistochemical and fluorescent antibody staining of embryos
and larvae
Collection, fixation, and immunohistochemical staining of embryos were
performed as previously described (Schulz and Fossett, 2005). The following
primary antibodies were used: mouse anti-β-galactosidase, 1:1000 (Promega);
rabbit anti-U-shaped, 1:750 (Fossett et al., 2001); rabbit anti-Serpent, 1:1000
(Hu, 1995). Either biotinylated (Vector Laboratories) or fluorescent (Molecular
Probes, Invitrogen) conjugated secondary antibodies were used for primary
antibody recognition, according to the manufacturer's recommendation. All
embryos were visualized with Zeiss Axioplan optics.
Lymph glands from the third instar wandering larvae were removed by
making an incision below the head region and removing the lymph gland, which
was attached to the dorsal vessel and brain. Fixation and immunostaining were
preformed as previously described (Schulz and Fossett, 2005). Stained
preparations were mounted in PBS under cover slips and visualized using
Zeiss Axioplan optics.
Gene expression analysis in mutant and Gal4/UAS embryos
Embryos were cultured and collected at 23 °C. Gain of function studies were
conducted using the Gal4/UAS binary system (Brand and Perrimon, 1993).
lz–lacZ activity in gain of function backgrounds required a two-generation
cross. Each lz–lacZ line was crossed to twi–Gal4 virgin females to produce
twi–Gal4/+; lz–lacZ /+ transheterozygous progeny. The F1 virgin females
were collected and then crossed to one of the following:UAS–srpNC or, UAS–lz
or, UAS–srpC or, UAS–srpNC;UAS–lz or, UAS–srpNC,UAS–ush homozygous
males or UAS–srpC/+;UAS–lz/+ heterozygous males. To assess lz–lacZ activity
in ush1 homozygous embryos also required a two-generation cross. Males
carrying lz–lacZ constructs on chromosome III were crossed to ush1/SM6,Roi,
eve–lacZ virgin females. F1 ush
1/+;lz–lacZ/+ transheterozygous progenies were
then intercrossed. Because Ush is required for germ band retraction,
homozygous mutants are easily identified by the altered morphology that
results from failure of the germ band to retract. In all cases, the F2 progenies
were collected during embryogenesis and assayed for β-galactosidase activity
using immunohistochemistry as previously described (Gajewski et al., 1997).
To assess Ush expression in Srp and Lz gain of function backgrounds,
homozygous twi–Gal4 virgins were crossed to homozygous UAS–srpNC;UAS–
lz males or, heterozygous UAS–srpNCV421G/+;UAS–lz/+ males. ush–lacZ
activity in gain of function backgrounds required a two-generation cross.
Each ush–lacZ line was crossed to twi–Gal4 virgin females to produce twi–
Gal4/+;ush–lacZ/+ transheterozygous progeny. The F1 virgin females were
collected and then crossed to one of the following: UAS–srpNC;UAS–lz or,
UAS–srpNC,UAS–ush homozygous males or, UAS–srpNCV421G/+;UAS–lz/+
or, UAS–srpNC,UAS–ush/+;UAS–lz/+ heterozygous males. The progenies from
these crosses were collected and immunohistochemically stained with either the
Ush or β-galactosidase antibody as previously described (Gajewski et al., 1997).Results
Identification of a lz minimal crystal cell cis-regulatory module
Both Srp isoforms can interact with Lz to activate the crystal
cell program (Fossett et al., 2003; Waltzer et al., 2003).
Conversely, SrpNC acting with Ush converts SrpNC from an
activator to a repressor of crystal cell production (Fossett et al.,
2003). These transcription factors may control crystal cell
production by directly regulating lz gene expression. In this
case, we expect that both activation by Srp and repression by
SrpNC:Ush would be mediated through GATA sites within the lzcrystal cell cis-regulatory module (CRM). To test this hypoth-
esis, we identified a 1.2 kb lz crystal cell CRM and then
determined which cis-elements are required for lz expression.
We employed a three-tiered strategy to narrow our search for
the lz crystal cell CRM. First, we used the lz–Gal4 fly line to
determine the approximate location of the CRM. In this fly line,
the promoter-less Gal4 cDNA (pGawB) is inserted into the lz
locus (Crew et al., 1997), which directs reporter-gene expression
in a pattern that recapitulates endogenous lz expression
(Lebestky et al., 2000). We determined that the pGawB insertion
site was 160 bp upstream of the transcription start site (Fig. 1A).
Based on this information, we then analyzed the region upstream
of the transcription start site for highly conserved sequences
between the melanogaster sibling species, sechellia, yakuba
and erecta. Such comparisons can help identify evolutionarily
conserved cis-elements. We identified three such regions at
positions −1169 to−827,−643 to−320, and−206 to the coding
region (Fig. 1A). Finally, because of our interest in Srp regulation
of lz gene expression, we searched this 1.2 kb region for GATA
motifs. This search identified 13 GATA motifs located between
positions −1207 and −768. Thus, we isolated and tested a DNA
fragment between positions −1263 and −18 for its ability to
drive crystal cell-specific reporter-gene (lacZ) expression in vivo
(Fig. 1A). lz–lacZ expression was first detected in embryonic
crystal cell precursors during stage 9 and continued throughout
development in this lineage (data not shown). Together, these
results indicate that a crystal cell CRM is located within the
1.2 kb region upstream of the transcription start site. However,
by stage 10, we also observed ectopic lz–lacZ expression that
continued throughout development in the ectoderm (data not
shown). Ectopic expression is defined as fragment-directed
reporter-gene activity that differed significantly from the pattern
produced by lz–Gal4 driving UAS–lacZ (Lebestky et al., 2000).
To identify the lzminimal crystal cell CRM,we subdivided the
1.2 kb region into 5 overlapping fragments. Fragment designa-
tions are based on their positions relative to the transcription start
site (Fig. 1A). Embryos harboring the −1236/−737 fragment
exhibited lz–lacZ expression in the crystal cell lineage starting
from stage 9 and continuing to stage 16 (Fig. 1B). We also
observed lz–lacZ expression in plasmatocytes for two of the six
lines tested, consistent with results seen with lz–Gal4;UAS–lacZ
embryos (Lebestky et al., 2000). In addition, one line showed
ectopic lz–lacZ expression in the amnioserosa and garland cells
(Fig. 1B, data not shown). A similar expression pattern was
detected in embryos harboring the −1019/−737 fragment
(Fig. 2B). As seen with the parental fragments, the −1019/
−931 fragment directed crystal cell-specific lz–lacZ expression
throughout embryonic development. However, embryonic
expression was first detected slightly later than with the parental
fragments, beginning in stage 10 rather than stage 9 (Fig. 1B). In
addition, one of the eight lines tested showed ectopic expression
in the amnioserosa (Fig. 3B, data not shown). We tested two
additional fragments from the 1.2 kb region. These two
fragments, −1236/−1018 and −737/0, were not able to direct
crystal cell-specific lz–lacZ expression (Fig. 1A). However, some
of the lines generated from each fragment exhibited ectopic and
plasmatocyte activity (data not shown).
Fig. 1. Identification of the lz crystal cell cis-regulatory module. (A) Schematic of the lz locus and screen for the crystal cell CRM. A horizontal arrow marks the
transcriptional start site, designated position 0. Solid lines indicate introns, whereas boxes indicate exons. The upstream c11.1 gene is depicted in grey. Beneath the
21 kb map is an expanded map of the 1.5 kb region upstream of the lz transcription unit. Evolutionarily conserved regions are highlighted in yellow. The relative
position of the P-element pGawB insert is indicated. The cryptic promoter used by this transgene likely lies just 5′ to the transcription start site. The DNA fragments
used to screen for crystal cell CRMs are indicated by black lines and are positioned and numbered relative to the transcription start site. Solid lines represent fragments
with crystal cell activity, whereas dashed lines represent fragments lacking crystal cell activity. The red diamonds designate representative data presented in part B. (B)
Fragment-driven reporter-gene (lacZ) expression during embryogenesis and in third larval instar lymph gland. The stage of embryogenesis is indicated at the left of
each row. The lz–lacZ strain designations are indicated at the top of each column. Orientation of the embryo is indicated to the right of each row. Solid arrows mark
activity and open arrows mark the lack of activity in stage 8 hemocyte precursors and stage 9 crystal cell precursors. The boundaries between the cortical and medullary
zones of the larval lymph glands are outlined. Abbreviations: lz, lozenge; llg, third larval instar lymph gland; cz, cortical zone; mz, medullary zone; L, lateral view; D,
dorsal view.
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lz, Bataille and co-workers published the crystal cell expression
pattern of a larger fragment located between −1509 and −59
(Bataille et al., 2005). They reported fragment-directed lz–lacZ
expression as early as stage 7 in hemocyte precursors. We
generated and analyzed 9 independent fly lines harboring this
fragment. All of the lines directed expression in the crystal celllineage throughout development. Seven lines had spatiotem-
poral expression similar to the −1236/−737 fragment, with
expression being first detected during stage 9, whereas lz–lacZ
expression was first detected during stage 8 in two of the lines
(Fig. 1B). However, these two lines also exhibited ectopic
expression, beginning during stage 10 and continuing through-
out embryonic development (data not shown). The observed
Fig. 2. Clustered GATA and RUNXmotifs are required for lz crystal cell CRM activity. (A) Schematic showing fragments with mutated GATA and RUNXmotifs used
to evaluate lz–lacZ CRM activity. The 1.5 kb region upstream of the lz transcription start site is depicted with the evolutionarily conserved regions highlighted in
yellow. Beneath the map of the 1.5 kb region is an expanded map of the region from −1250 to −727. Red vertical lines show the relative positions of the 13 GATA
motifs between positions −1207 and −768. The blue diamonds mark the positions of the two RUNX motifs located at −995 and −977. Mutations in the four GATA
motifs, between positions −1010 and −947, are designated G4m, whereas the mutations in the two RUNX motifs are designated R2m. The mutated fragments are
numbered and positioned relative to the transcription start site, with the suffix G4m or R2m to indicate disruption of the GATA or RUNX motifs, respectively. Solid
line represents a fragment with crystal cell activity, whereas dashed lines represent fragments lacking crystal cell activity. (B) Comparison of wild-type and GATA or
RUNX mutant CRMs. Dorsal views of stage 13 embryos. lz–lacZ strains are indicated in the lower right hand corner of each panel. Closed arrows mark activity in
crystal cells; open arrows mark lack of activity. Abbreviations: G4m, GATA Core mutants; R2m, RUNX mutants.
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be due to methodological differences between laboratories. The
difficulty in detecting a signal from a low-level transcript could
explain the variance seen with staging in this study. In any case,
the results with the −1509/−59 and −1236/−737 fragments
indicate that lz expression is upregulated by stage 9. The
possibility of earlier activity during stage 7 or stage 8 prompted
us to determine if an additional crystal cell-specific CRM was
located upstream of the 1.2 kb fragment. We tested the region
between positions −1509 and −1210, but did not detect
fragment-driven lz–lacZ activity in the crystal cell lineage (Fig.
1A, data not shown).
Our analysis of the lz 5′non-coding region indicated that
genomic fragments lacking the −1019/−931 region were
unable to drive lz–lacZ expression in the crystal cell lineage.
Thus, the −1019/−931 fragment most likely contains a minimal
CRM that is required for lz expression during crystal cell
development. However, lz −1019/−931 lacZ activity was
detected during stage 10, slightly later in development than
that of the larger −1509/−59 or −1236/−737 fragments (Fig.
1B). This suggests that regions outside of the −1019/−931
CRM are also required for early activation of lz expression in
crystal cell precursors.We also tested the activity of the −1509/−59, −1236/−737,
and −1019/−931 fragments in the third larval instar lymph
gland (Fig. 1B). The third larval instar lymph gland is a set of
bilateral primary lobes and a series of smaller secondary lobes
that flank the dorsal vessel (insect heart). Morphological,
functional, and gene expression analyses indicate that the
primary lobes are divided into three distinct regions, namely, the
cortical zone, the medullary zone and the posterior signaling
center. Lz is expressed in the cortical zone, but not in the
medullary zone (Lebestky et al., 2000; Jung et al., 2005).
Consistent with these reports, all three fragments directed lz–
lacZ expression in the cortical zone, but not in the medullary
zone (Fig. 1B). Together, these data show that the lz −1019/
−931 lacZ expression pattern recapitulates the endogenous lz
expression pattern, indicating that it is required for lz expression
during both embryonic and larval lymph gland hematopoiesis.
Clustered GATA and RUNX sites are required for lz minimal
crystal cell CRM activity
Our analyses of the lz cis-regulatory region showed that a
minimal CRM located between positions −1019 and −931 can
direct lz expression in crystal cells. In order to identify trans-
Fig. 3. SrpNC is a positive and negative regulator of lz crystal cell CRM activity. (A) SrpNC and Lz synergistically upregulate lz −1019/−931 lacZ activity. From left
to right: embryos in the first four columns are stained with α–β-galactosidase antibody; embryos in the last column are stained with α-Srp antibody. (B) SrpNC and
Ush block lz −1019/−931 lacZ activity. lz −1019/−931 lacZ activity was assessed in different genetic backgrounds and developmental stages. The stage of
embryogenesis is indicated at the left of each row. The genetic background is indicated at the top of each column. Orientation of the embryo is indicated at the right of
each row (panel A only). SrpNC indicates twi–Gal4 driving UAS–srpNC. Lz indicates twi–Gal4 driving UAS–lz. SrpNC;Lz represents twi–Gal4 driving UAS–srpNC
and UAS–lz located on chromosomes II and III, respectively. SrpNC,Ush represents twi–Gal4 driving UAS–srpNC and UAS–ush located on chromosome II. Closed
arrows mark increased activity in crystal cells; open arrow marks lack of activity; arrowhead marks ectopic expression in the amnioserosa, which is used to identify
embryos carrying the reporter gene. Abbreviations: wt, wild-type; Srp, Serpent; Lz, Lozenge; Ush, U-shaped; L, lateral view; D, dorsal view.
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−931 sequence for cis-regulatory elements that may be required
for crystal cell activity. This sequence contains four GATA
motifs with the following distribution: two overlapping motifs
at positions −1010 and −1008, one at −957, and one at −947.
We also identified two RUNX motifs at positions −995 and
−977 (Fig. 2A). To determine if these elements are required for
lz crystal cell expression, we introduced point mutations into
either the GATA or RUNX motifs. We mutated all four GATA
sites between positions −1010 and −947 and assigned this
mutation the name G4m (Fig. 2A). The −1019/−931 G4m
fragment failed to direct lz–lacZ expression in crystal cells (Fig.
2B). This indicates that Srp binds these sites to upregulate lz in
the crystal cell lineage. Based on the functional requirement of
these four sites, we designated this cluster the GATA Core.
Of the 13 GATA motifs within the −1236/−737 region, nine
are located outside of the GATA Core. Four of the nine are
located upstream of the Core, between positions −1207 and
−1081, and are designated the Upstream Cluster. The
remaining five are located downstream of the Core, between
positions −848 and −768, and are designated the Downstream
Cluster (Fig. 2A). To determine the functionality of these sites,
we constructed two different fragments. Both fragments carried
mutant versions of the GATA Core. Using the convention
described above, the fragments were designated by their
positions relative to the transcription start site, with the suffix
G4m used to indicate disruption of the GATA Core. Thus, the
−1019/−737 G4m fragment had a mutated GATA Core, but awild-type version of the Downstream Cluster (Fig. 2A). This
fragment was unable to direct lz–lacZ expression in crystal
cells (Fig. 2B). Thus, the Downstream Cluster does not activate
lz expression in crystal cells in the absence of the GATA Core.
In contrast, we detected crystal cell activity in the −1236/−931
G4m fragment (Fig. 2B). This indicates that the Upstream
Cluster can compensate for the loss of the GATA Core and may
function in the activation of lz expression. The functional
difference between the Upstream and Downstream Clusters
may reflect the fact that three of the four Upstream GATA
motifs are conserved consensus (WGATAR) motifs across
sibling species. In contrast, the Downstream Cluster contains
only one consensus motif and two conserved motifs (Fig. 2A,
data not shown). Together, these observations are consistent
with studies that show GATA-1 activates β-globin gene
expression using a subset of GATA motifs within the locus,
and that GATA occupancy occurs more often among conserved
consensus motifs (Im et al., 2005; Bresnick et al., 2006).
Finally, these data strongly indicate that Srp directly upregu-
lates lz activity in crystal cells by binding to specific GATA
motifs.
Although the −1236/−931 G4m fragment directed lz–lacZ
expression in crystal cells, the −1236/−1018 sub-fragment
failed to do so (Figs. 1A, 2). The difference in activity between
these two fragments is due to the cis-elements located between
positions −1019 and −931. As stated above, this region
contains the GATA Core and two RUNX motifs. Because the
Upstream GATA Cluster was able to compensate for the four
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essential elements that are required to direct crystal cell activity.
Furthermore, the functional Upstream Cluster is closer to the
RUNX motifs than the nonfunctional Downstream Cluster,
suggesting that cooperation between Lz and Srp may be
necessary for lz expression. Based on these observations, we
disrupted the two RUNX motifs within the −1019/−737
fragment and assigned this mutation the name R2m (Fig. 2A).
This mutation completely abolished the crystal cell activity of
the −1019/−737 fragment in nine out of ten lines tested,
suggesting that Lz functions as an auto-activator in a positive
feedback loop (Fig. 2B). Together, the mutational analysis
strongly suggests that both GATA and RUNX motifs within the
minimal −1019/−931 CRM are required for lz crystal cell CRM
activity. Moreover, these data are consistent with studies
showing that crystal cell-specific CRMs in a number of
genes, including lz, contain at least one essential RUNX motif
(Muratoglu et al., 2006; Gajewski et al., 2007; Ferjoux et al.,
2007). However, the functional Upstream GATA Cluster may
act with either the two RUNX motifs and/or the GATA Core to
direct crystal cell-specific activity, and this question is the
subject of continuing studies.
Dual role of SrpNC as a positive and negative regulator of lz
crystal cell expression
SrpNC may function as a contextual switch by acting with
Lz to activate the crystal cell program or with Ush to block
activation (Fossett et al., 2003). Lz is required for crystal cell
lineage commitment (Lebestky et al., 2000), and GATA and
RUNX motifs within the lz minimal −1019/−931 CRM are
most likely required for its expression (Fig. 2B). Together,
these observations strongly suggest that SrpNC cross-regulates
lz expression through the GATA and RUNX motifs within the
minimal −1019/−931 CRM, thereby controlling crystal cell
lineage commitment. To address this question, we assayed the
lz minimal −1019/−931 CRM for activity in embryos with
altered levels of SrpNC, Lz, or Ush, either individually or in
combination.
Forced mesodermal expression of SrpNC increased lz
−1019/−931 lacZ expression. Expression was detected in the
stage 9 head mesoderm, earlier than in a wild-type background
(Fig. 3A). The expanded expression pattern is reminiscent of the
supernumerary crystal cell pattern produced by forced expres-
sion of both Srp isoforms (Fossett et al., 2003; Waltzer et al.,
2003). Similar results were observed with SrpC (data not
shown). Forced expression of Lz also increased the lz–lacZ
expression domain in a pattern similar to the expression pattern
of endogenous Srp (Fig. 3A). This indicates that Srp and Lz
interact to activate lz −1019/−931 lacZ through the GATA and
RUNX motifs. This was confirmed by showing that co-
expression of SrpNC and Lz synergistically upregulated lz
−1019/−931 lacZ. We observed strong lz −1019/−931 lacZ
expression throughout the head mesoderm and weak expression
in trunk mesoderm beginning in stage 9. By stage 12, strong
expression was observed throughout the mesoderm, in stark
contrast to results obtained with forced expression of eitherfactor alone (Fig. 3A). Similar results were obtained with SrpC
(data not shown). These results indicate that both Srp isoforms
can interact with Lz to upregulate lz expression in crystal cells
through the GATA and RUNX motifs located within the
minimal CRM.
The functional role of the GATA motifs within the lz crystal
cell CRM suggested that the SrpNC:Ush complex binds these
motifs to block lz expression. To test this hypothesis, we
examined lz −1019/−931 CRM activity in ush loss of function
and SrpNC:Ush gain of function genetic backgrounds.
Compared to the wild-type control, lz −1019/−931 CRM
activity increased in a ush mutant background (Fig. 3B).
Similar results were observed with the larger −1236/−737
fragment that contained all 13 GATA motifs (data not shown),
indicating that Ush is required to limit the lz expression domain.
Consistent with these results, forced expression of SrpNC and
Ush blocked lz −1019/−931 CRM activity (Fig. 3B). We
observed similar results with the larger −1509/−59 and −1236/
−737 fragments (data not shown). Thus, the SrpNC:Ush
complex blocked lz expression through the GATA sites within
the minimal CRM. Together, these data indicate that SrpNC acts
as cross-regulatory switch by interacting with Lz to maintain lz
expression or with Ush to block lz expression. Collectively, our
new data, coupled with our previously published results,
indicate that the SrpNC:Ush complex blocks crystal cell
production by blocking lz expression (Fig. 3B; Fossett et al.,
2001, 2003). Finally, forced expression of SrpNC and Ush did
not block gcm–lacZ-expressing hemocyte precursors or plas-
matocytes (data not shown). These results indicate that the
SrpNC:Ush complex does not limit the production of these
hemocyte classes. To increase our understanding of the cross-
regulatory process and how it modulates crystal cell production,
we expanded our investigation of ush expression during crystal
cell lineage commitment.
Ush expression is upregulated after crystal cell lineage
specification
Ush is expressed in a variety of tissues throughout
embryogenesis, including the following hematopoietic tissues:
hemocyte precursors, plasmatocytes, and crystal cells (Fossett
et al., 2001, 2000). Previously, we identified a ush −7462/−25
CRM, which recapitulates endogenous Ush embryonic expres-
sion. Our analyses of sub-fragments from the −7462 to −25
region showed that two hematopoietic CRMs are located
within 1.2 kb of the transcription start site. The distal −1243/
−956 CRM drives expression in hemocyte precursors and
plasmatocytes but not crystal cells, whereas the proximal
−174/−25 CRM is required for expression in all three cell
types. Genetic and mutational analyses of these hematopoietic
CRMs showed that Srp activates expression in hemocyte
precursors and plasmatocytes through the GATA motifs within
both CRMs, whereas both Srp and Lz activate expression in
crystal cells through clustered GATA and RUNX motifs unique
to the −174/−25 CRM (Muratoglu et al., 2006).
During embryonic development, Srp is first detected in stage
5 hemocyte precursors (Rehorn et al., 1996; Sam et al., 1996).
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late as stage 9 (Fig. 1B). And, Ush is detected in hemocyte
precursors during stage 8 and in crystal cell precursors again
later during stage 10. During stage 13 and continuing through
the end of embryogenesis, Ush is increasingly downregulated in
the crystal cell lineage (Fossett et al., 2001). However, it is not
known whether ush expression is maintained as hemocyte
precursors develop into crystal cell precursors, or if expression
is upregulated after lineage specification. To more accurately
assess the timing of Ush expression, we determined the level of
co-expression of Ush with lz −1236/−737 lacZ in early crystal
cell precursors. We observed lz −1236/−737 lacZ expression in
crystal cell precursors as early as stage 9. In contrast, Ush
expression was not detected in these cells. However, beginning
in stage 10 and continuing through stage 11, we observed
extensive co-expression of lz −1236/−737 lacZ and Ush in
crystal cell precursors (Fig. 4, data not shown), consistent with
our previous observations (Fossett et al., 2001). Similar resultsFig. 4. lz–lacZ and Ush expression during crystal cell development. The lz −1236/−
expression is depicted in red. Co-localized expression is depicted in yellow. The stag
marked by a white dotted box. Arrows mark the following: stage 9 cells expressing o
stage 12 cells expressing only Ush. Abbreviations: lz–lacZ, lz −1236/−747 lacZ; Uwere observed with the larger −1509/−59 fragment (data not
shown). Thus, Ush expression is not maintained as hemocyte
precursors develop into crystal cell precursors, but is upregu-
lated after lineage specification.
During stage 12, we continued to observe co-expression of
Ush and lz −1236/−737 lacZ. However, adjacent to lz −1236/
−737 lacZ-positive cells and within the crystal cell cluster, we
also observed cells that expressed only Ush (Fig. 4). The
morphology and position of these cells suggest that they are
derived from lz–lacZ-positive precursors. Moreover, these cells
were primarily Ush-positive, lz–lacZ-positive during stages 10
and 11 (Fig. 4; Fossett et al., 2001). Together, these observations
are consistent with downregulation of lz −1236/−737 lacZ by
the endogenous SrpNC:Ush complex to specify a Ush-positive,
lz–lacZ-negative state. This interpretation is also in agreement
with our results that showed forced expression of SrpNC and
Ush blocked lz CRM activity and that lz–lacZ activity increased
in a ush mutant background (Fig. 3B). Finally, during stage 13737 CRM was used to assess lz expression and is depicted in green. Ush protein
e of embryogenesis is indicated at the top of each column. The enlarged area is
nly lz–lacZ; stage 10 cells with co-localized expression of lz–lacZ and Ush; and
sh, U-shaped; co, co-localization.
Fig. 5. N-terminal zinc-finger conserved valine residue is required for SrpNC
and Lz repression of ush expression. (A) Ush protein expression and (B) ush
−7462/−25 lacZ activity was assessed in stage 13 embryos with different
genetic backgrounds. The genetic background is indicated at the top of each
column. Orientation of the embryo is indicated at the right of each row. SrpNC;
Lz represents twi–Gal4 driving UAS–srpNC and UAS–lz located on chromo-
somes II and III, respectively. SrpNC;V421GLz represents twi–Gal4 driving
UAS–srpNCV4216 and UAS–lz located on chromosomes II and III, respectively.
Open arrows mark lack of expression in hemocytes. Abbreviations: wt, wild-
type; Srp, Serpent; Lz, Lozenge; Ush, U-shaped; L, lateral view; D, dorsal view.
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increasing number of lz–lacZ-positive cells with greatly
diminished Ush expression (data not shown), consistent with
previous studies (Fossett et al., 2001).
Ush acting with SrpNC downregulates ush hematopoietic
expression
We previously showed that Ush is downregulated in embryos
with forced expression of SrpNC and Lz. In contrast, forced
expression of SrpC and Lz did not inhibit expression. This
suggests that the N-terminal zinc-finger of Srp is essential for
repression (Fossett et al., 2003). The GATA N-terminal zinc-
finger stabilizes DNA binding and serves as a protein
interaction domain (Pedone et al., 1997; Crispino et al., 1999;
Newton et al., 2001). Ush interacts with SrpNC through a
conserved valine residue at position 421 (Crispino et al., 1999;
Fossett et al., 2003). To investigate the mechanism of ush gene
repression, we co-expressed Lz with the N-terminal zinc-finger
mutant SrpNCV421G and assayed for endogenous Ush expres-
sion. Similar to results obtained with SrpC and Lz, SrpNCV421G
and Lz did not repress Ush expression (Fig. 5A). We repeated
these studies using the ush −7462/−25 lacZ CRM and, as with
endogenous Ush, observed downregulation of ush–lacZ in
embryos with forced expression of SrpNC and Lz, but not in
those with forced expression of SrpNCV421G and Lz (Fig. 5B).
Together, these data suggest that Ush acting with SrpNC is an
auto-repressor of its hematopoietic expression. Furthermore,
forced expression of SrpNCV421G and Lz upregulated, but did
not repress, endogenous Ush or ush −7462/−25 lacZ expres-
sion (Fig. 5). This is consistent with our previous work that
showed at least one Srp isoform acts with Lz to upregulate ush
expression in crystal cells (Muratoglu et al., 2006). Together,
these data suggest that SrpNC and Lz initially activate ush
expression. Subsequently, Ush acts with SrpNC to down-
regulate its hematopoietic expression. Consistent with a cross-
regulatory process, forced expression of SrpNC and Lz
produced individuals with either downregulated or upregulated
ush −7462/−25 lacZ activity when compared to the wild-type
control (Fig. 5B, data not shown).
Ush competes with Lz to control SrpNC regulation of ush gene
expression
Ush auto-repression may occur by one of two possible
mechanisms. First, Ush could interact with SrpNC and Lz to
form a complex that blocks ush expression. Alternatively, Ush
may compete with Lz by converting SrpNC from an activator to
a repressor of ush gene expression in a similar manner to control
of SrpNC regulation of lz gene expression. To determine if Lz is
required for inhibition, we ectopically expressed SrpNC and Lz,
SrpNC and Ush, or all three factors together and assayed ush
−7462/−25 lacZ activity. As with forced expression of SrpNC
and Lz, forced expression of all three factors downregulated ush
−7462/−25 lacZ in embryonic hemocytes (Fig. 6A). We also
observed embryos with increased ush −7462/−25 lacZ activity
(data not shown). In contrast, forced expression of SrpNC andUsh completely blocked ush −7462/−25 lacZ expression in
hemocytes throughout the entire embryo population. Moreover,
SrpNC and Ush completely blocked ush −7462/−25 lacZ
activity in plasmatocytes, whereas residual activity remained in
a sub-population of plasmatocytes with either forced expression
of SrpNC and Lz or forced expression of all three factors (Fig.
6A). Collectively, these results show that SrpNC and Ush
repressed ush −7462/−25 lacZ expression more effectively in
the absence of ectopic Lz. In addition, forced expression of
SrpNC and Ush did not block production of gcm–lacZ-
expressing plasmatocytes but did block ush expression (data
not shown). Finally, two observations show that the SrpNC:Ush
complex can block ush expression without first downregulating
the trans-activator Lz. First, the SrpNC:Ush complex blocked
ush −7462/−25 lacZ activity in plasmatocytes, which do not
express Lz. Second, the complex blocked ush −7462/−25 lacZ
activity even in the presence of ectopic Lz (Fig. 6A). Together,
these data support cross-regulatory control of ush expression,
with activation by SrpNC and Lz and repression by SrpNC and
Ush.
Fig. 6. Ush competes with Lz to control SrpNC regulation of ush expression. (A)
ush −7462/−25 lacZ and (B) ush −174/−25 lacZ was assessed in different
genetic backgrounds and developmental stages. The stage of embryogenesis is
indicated at the left of each row. All embryos are lateral views. The genetic
background is indicated at the top of each column. SrpNC;Lz represents twi–
Gal4 driving UAS–srpNC and UAS–lz located on chromosome II and III,
respectively. SrpNC,Ush represents twi–Gal4 driving UAS–srpNC and UAS–
ush located on chromosome II. SrpNC,Ush;Lz indicates twi–Gal4 driving UAS–
srpNC, UAS–ush and UAS–lz located on chromosomes II and III, respectively.
Plasmatocytes and crystal cells (outlined in panel A) are marked with arrows:
closed arrows indicate wild-type CRM activity; open arrows indicate reduced
activity; open dotted arrows indicate lack of activity. The level of CRM activity
in the head mesoderm is marked with arrowheads: closed arrowheads indicate
increased activity; the open arrowhead indicates lack of activity. Abbreviations:
wt, wild-type; Srp, Serpent; Lz, Lozenge; Ush, U-shaped; cc, crystal cells; pl,
plasmatocytes.
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−174/−25 CRM, which directs lacZ expression in hemocyte
precursors, plasmatocytes, and crystal cells. This minimal
hematopoietic CRM has a single RUNX motif and three GATA
motifs, which are required for activity in the crystal cell lineage
(Muratoglu et al., 2006). We next asked whether activation of
ush expression by SrpNC and Lz and repression by SrpNC:
Ush were mediated through this CRM. Forced expression of
SrpNC and Lz upregulated the ush −174/−25 CRM, producing
pan-mesodermal expression by stage 12. This activity wassomewhat reduced when all three factors were expressed
together. In contrast, forced expression of SrpNC and Ush, in
the absence of ectopic Lz, inhibited ush −174/−25 lacZ
expression when compared to the wild-type control (Fig. 6B).
These results indicate that both activation and repression can be
mediated through the ush −174/−25 CRM. Together, these
results and those obtained with the larger −7462/−25 fragment
indicate that SrpNC and Lz activate, whereas SrpNC and Ush
repress, ush hematopoietic expression.
We observed differences between the ush minimal −174/
−25 CRM and the larger −7462/−25 fragment suggesting that
the upstream −7462 to −174 region is important for the
repression of ush by SrpNC and Ush. Specifically, in contrast to
the −7462/−25 CRM, forced expression of SrpNC, Lz and Ush
did not downregulate the −174/−25 CRM to levels below that
of wild-type (Fig. 6, compare A and B). This difference
suggests that the SrpNC:Ush complex may function to repress
ush hematopoietic expression through binding to GATA motifs
within the −7462 to −174 region, thereby blocking activation
of ush expression by competing with Lz. In this regard, there is
a stark contrast between the −7462/−174 and the −174/−25
regions with respect to GATA/RUNX motif clustering. The
−174/−25 region has one RUNX and three GATA motifs
clustered within 83 bp. This is similar to the lz minimal CRM,
which has four GATA and two RUNX motifs within 88 bp. In
contrast, the −7462/−174 region has 19 GATA motifs and two
RUNX motifs. However, the RUNX motifs are separated from
the nearest GATA motif by at least 80 bp. The proximity of the
GATA and RUNX motifs appears to be a key feature in the co-
activation by Srp and Lz (Ferjoux et al., 2007). Thus, the
architecture of the −7462/−174 region may favor SrpNC:Ush
complex binding over Srp/Lz binding, whereas the −174/−25
region appears to accommodate both SrpNC:Ush and Srp/Lz
binding. Increased binding of the SrpNC:Ush complex to the
GATA motifs within the −7462 to −174 region may increase
the ability of the SrpNC:Ush complex to repress ush expression
in the presence of ectopic Lz. Overall, these results show that
the SrpNC:Ush complex negatively regulates ush expression
and that Ush competes with Lz to control SrpNC regulation of
ush gene expression.
Discussion
Here, we present a gene regulatory basis for combinatorial
control of crystal cell production by Srp, Lz, and Ush. Our
results show that Srp cross-regulates lz and ush through the
GATA/RUNX motifs within the hematopoietic CRMs of both
genes. This gene regulatory sub-circuit functions to modulate lz
expression. The sub-circuit specifies a dynamic bi-potential
regulatory state in crystal cell precursors by co-activating lz and
its repressor ush. Subsequently, the sub-circuit contributes to
the selection of a Lz-positive or Lz-negative state, which
regulates crystal cell production.
Lz is upregulated in hemocyte precursors and is required for
crystal cell lineage specification and differentiation (Lebestky et
al., 2000; Bataille et al., 2005). To more fully understand the
control of crystal cell production, we began by investigating the
646 S. Muratoglu et al. / Developmental Biology 311 (2007) 636–649transcriptional regulation of lz expression. We identified a lz
minimal CRM and showed that it directs expression in the
crystal cell lineage. Our results showed that Srp activates lz–
lacZ reporter-gene expression by binding to the GATA motifs
within this CRM. Specifically, mutational analyses of the lz
CRM showed that the GATA motifs were required for
activation. In addition, forced expression of Srp produced
both early activation of the lz CRM and an expanded expression
domain when compared to the wild-type control. Moreover, this
expression pattern was reminiscent of the supernumerary crystal
cell pattern produced by forced expression of Srp (Fossett et al.,
2003; Waltzer et al., 2003). Together, these observations
indicate that lz is directly activated by Srp as a prerequisite
for crystal cell specification.
In addition to the GATA motifs, lz CRM activity requires
canonical RUNX motifs. This indicates that positive auto-
regulation of lz is involved during crystal cell commitment and
development. Autoregulation is likely a conserved property of
the Runx gene family. RUNX2 has been shown to both
positively and negatively autoregulate its expression in
osteoblasts (Ducy et al., 1999; Drissi et al., 2000). In addition,
all three mammalian Runx genes carry canonical RUNX motifs
within their respective cis-regulatory regions, suggesting that
Runx1 and Runx3 are autoregulated as well (Otto et al., 2003;
Smith et al., 2005). However, Lz autoregulation requires
cooperative interaction with Srp, evidenced by the fact that
mutation of either the GATA or RUNX motifs completely
blocked lz CRM activity throughout embryonic development.
Moreover, forced co-expression Srp and Lz synergistically
activated the lz CRM. Together, these results and the recent
report of Ferjoux et al. (2007) indicate that both Srp and Lz
interact to maintain lz expression during crystal cell commit-
ment and development.
Srp and Lz are also required to activate ush expression in
crystal cell precursors (Muratoglu et al., 2006). This gene
regulatory sequence, where Srp activates lz and then both Srp
and Lz are required to co-activate ush, constitutes a feed forward
regulatory motif. This type of motif determines the order of gene
expression and controls the temporal expression of the down-
stream target (Mangan and Alon, 2003; Swiers et al., 2006).
Accordingly, we observed Ush expression in the crystal cell
lineage after the onset of lz–lacZ expression. Thus, this design
insures that the crystal cell precursors are specified by Lz before
upregulation of the repressor Ush. This is essential because
premature activation of the SrpNC:Ush complex completely
blocked lz CRM expression and crystal cell production.
After the initial specification of the crystal cell precursors,
Srp and Lz maintain lz and upregulate ush through clustered
GATA/RUNX motifs within the CRMs of both genes. As a
result, lz–lacZ and Ush were co-expressed in the crystal cell
lineage from embryonic stage 10 through 14. The co-expression
of Lz and its antagonist Ush forms the basis for the bi-potential
nature of the crystal cell precursor. As such, this regulatory state
provides the precursor with the option of progressing towards
either the Lz-positive or Lz-negative state. Thus, Srp and Lz co-
regulation of crystal cell development involves more than just
activation of the crystal cell program, but rather includes thespecification of a dynamic bi-potential regulatory state.
Furthermore, Srp and Lz activate two crystal cell-specific
genes (prophenoloxidases; proPOs) in stage 11 precursors
through GATA/RUNX sites within the CRMs of each gene
(Gajewski et al., 2007; Ferjoux et al., 2007). The co-expression
of Ush with these crystal cell-specific genes may be consistent
with lineage priming, showing that regulators of opposing
pathways are expressed in bi-potent precursors prior to lineage
commitment (Hu et al., 1997; Orkin, 2000; Warren and
Rothenberg, 2003; Ye et al., 2003; Huang et al., 2007).
Collectively, these results indicate that Srp and Lz direct ush
expression as part of a feed forward motif, which insures that
the bi-potential regulatory state is established after crystal cell
specification and before lineage commitment. Finally, in the
dynamic bi-potential regulatory state, where Ush and Lz
compete with SrpNC to cross-regulate each other, the expected
phenotypic heterogeneity is reflected in the co-localization of
lz–lacZ and Ush during embryonic stages 12 through 14.
Initially, we observed lz–lacZ-positive, Ush-positive precursors.
By embryonic stage 12, the population included cells that
expressed only Ush (lz–lacZ-negative, Ush-positive). During
stage 13, we observed a third cell type (lz–lacZ-positive with
diminished Ush expression).
As part of the Srp cross-regulatory sub-circuit, both Srp
isoforms can act with Lz to maintain lz expression and activate
ush to produce the bi-potential regulatory state. However, only
SrpNC can mediate cross-antagonism between Lz and Ush and,
thereby, the selection of the Lz-positive or Lz-negative state.
This illustrates the importance of alternative splicing of srp
(Fossett et al., 2001; Waltzer et al., 2002) as a determinant of lz
gene regulation. The role of the SrpNC:Ush complex in
selecting the Lz-negative state is supported by our results that
showed forced expression of SrpNC and Ush blocked lz CRM
activity, whereas CRM activity increased in ush mutant
embryos. Thus, Ush converts SrpNC from an activator to a
repressor that blocks lz expression through the GATA motifs
within the crystal cell CRM. This contributes to the selection of
the Lz-negative state, thereby preventing the bi-potential
precursor from becoming a terminally differentiated crystal
cell. Overall, this limits crystal cell number. Thus, these results
provide a gene regulatory basis for our previous studies that
showed the SrpNC:Ush complex limits crystal cell production
(Fossett et al., 2003). Moreover, Lz-expressing crystal cell
precursors can give rise to either Lz-positive crystal cells or Lz-
negative plasmatocytes (Lebestky et al., 2000; Bataille et al.,
2005), and the modulation of lz expression is most likely a
critical determinant of cell fate choice. Therefore, the SrpNC:
Ush complex may contribute to selection of the plasmatocyte
lineage by downregulating lz expression, thereby terminating
the crystal cell developmental program to stabilize plasmatocyte
cell fate choice.
SrpNC-mediated cross-antagonism of Lz and Ush is a
dynamic process. SrpNC and Ush not only blocked lz
expression, but the SrpNC:Ush complex can also block ush
expression in crystal cells and plasmatocytes. This limits the
formation of the SrpNC:Ush complex and, thereby, its capacity
to regulate gene expression in these cells. In plasmatocytes, the
Fig. 7. Model of Srp cross-regulatory control of crystal cell lineage commitment.
(A) Combinatorial control of crystal cell lineage commitment by Srp, Lz, and
Ush. Srp acts as a contextual switch, interacting with Lz to activate crystal cell
lineage commitment and with Ush to block crystal cell production. (B) Srp
cross-regulatory control of lz and ush expression. Srp and Lz interact to
maintain the Lz-positive regulatory state. These transcriptional regulators also
activate ush expression in Lz-positive crystal cell precursors to produce a
dynamic, bi-potential regulatory state. SrpNC mediates cross-antagonism of Lz
and Ush, acting with Lz to maintain the Lz-positive state or with Ush to select
the Lz-negative regulatory state. Additionally, the SrpNC:Ush complex can
downregulate ush expression, thereby limiting the capacity of the complex to
block lz expression. Srp cross-regulatory control of lz and ush is mediated
through the GATA and RUNX binding sites within the minimal hematopoietic
CRMs of each locus. Green arrows indicate the activation pathway. Red arrows
and blocked red lines indicate the repression pathway. The blocked black line
indicates relief of repression. Abbreviations: Srp, Serpent; Lz, Lozenge, CC,
crystal cells; Ush, U-shaped.
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important component of the programmed cell death pathway
(Franc et al., 1999; Waltzer et al., 2002). Thus, negative
regulation of ush may relieve croquemort repression preparing
plasmatocytes to function during programmed cell death. In
crystal cells, downregulation of ush limits the capacity of the
SrpNC:Ush complex to block lz expression. This may provide
an additional regulatory tier that prevents the complete
repression of lz expression in bi-potent crystal cell precursors.
The net effect would be to increase the availability of SrpNC to
act with Lz to maintain the Lz-positive state. As part of the Srp
cross-regulatory sub-circuit, subtle changes in the relative levels
of SrpC and SrpNC may be involved in locking on the Lz-
positive, Ush-negative regulatory state. These differences
would be mediated through the distinct characteristics of the
individual CRMs, within the overall architecture of the cross-
regulatory sub-circuit, resulting in the shift to the Lz-positive,
Ush-negative state. This subject is also being investigated in our
laboratory as part of the larger gene regulatory network that
controls crystal cell commitment and development.
Together, these studies provide the basis for a model of
Drosophila hematopoiesis that describes the regulation of lz
expression and, as a result, blood cell production. Although the
totality of the regulatory process remains to be determined, this
model builds on previous studies of crystal cell specification
and development and describes the events that occur after the
initial activation of lz by Srp. Subsequently, the Lz-positive
state is maintained by cooperative interaction between Srp and
Lz. These transcriptional regulators also activate ush expression
in Lz-positive crystal cell precursors to produce a dynamic, bi-
potential regulatory state. This provides for the selection of
either a Lz-positive or Lz-negative state, which is determined in
part by SrpNC-mediated cross-antagonism of Lz and Ush (Fig.
7). This model is also consistent with the observation that a
number of factors involved in cell fate control function as
components of cross-regulatory and auto-regulatory sub-
circuits (Orkin, 2000; Swiers et al., 2006; Huang et al., 2007).
Furthermore, the Srp cross-regulatory sub-circuit controls blood
cell development as one part of a larger gene network. This sub-
circuit is undoubtedly interlinked to additional sub-circuits that
control related functions, such as the regulation of alternative
splicing of the srp transcript to produce either the SrpNC or
SrpC isoform (Fossett et al., 2001; Waltzer et al., 2002). Finally,
the dynamic regulation of these hematopoietic factors is
consistent with the observed population heterogeneity as crystal
cell precursors progress from a bi-potential regulatory state to
either a Lz-positive or a Lz-negative state.
Aspects of GATA, FOG and RUNX functions are conserved
between the fly and vertebrates. Our studies provide new
information describing how these factors may interact to
regulate Runx and Fog gene expression in Drosophila.
Specifically, this study presents the first demonstration of
GATA:FOG regulation of Runx gene expression. This may be
particularly important to the understanding of vertebrate
hematopoiesis because GATA, FOG and RUNX factors are
co-expressed and required for megakaryopoiesis (Tsang et al.,
1997, 1998; Song et al., 1999; Gaines et al., 2000; Nichols et al.,2000; Freson et al., 2001; Mehaffey et al., 2001; Cantor et al.,
2002; Chang et al., 2002; Michaud et al., 2002; Walker et al.,
2002; Yu et al., 2002; Elagib et al., 2003; Tanaka et al., 2004). In
addition, little is known about how Runx gene expression is
regulated during this process (Otto et al., 2003; Swiers et al.,
2006). We also present the first demonstration of FOG
autoregulation. This finding may provide insights into regula-
tion of vertebrate Fog genes, thereby increasing our under-
standing of the mechanisms by which these transcriptional
regulators modify the function of GATA factors.
During vertebrate hematopoiesis, multipotent progenitors
express lineage specific factors prior to lineage commitment (Hu
et al., 1997; Orkin, 2000; Warren and Rothenberg, 2003; Ye et
al., 2003). This constitutes a dynamic regulatory state that
provides for multiple developmental options (Orkin, 2000). As a
result, lineage commitment can involve cross-antagonism to
select one developmental program and repress alternative lineage
programs (Orkin, 2000; Cantor and Orkin, 2005). Our studies
have identified a gene regulatory sub-circuit that produces a
dynamic, bi-potential regulatory state that contributes to
selection of one of two possible regulatory pathways, consistent
with these models of vertebrate hematopoiesis. Finally, this
provides a mechanistic basis for the combinatorial control of
blood cell development by Srp, Lz, and Ush and a framework for
future investigations of Drosophila hematopoiesis.
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